The American Acne and Rosacea Society (AARS) Highlights #RosaceaFacts During Rosacea Awareness Month

MONTCLAIR, N.J. - Amzeal -- April is Rosacea Awareness Month, and the American Acne and Rosacea Society (AARS) continues to educate its members and their patients about the signs and symptoms of this common inflammatory skin disease that most often affects the face. AARS members are sharing #RosaceaFacts and highlighting the availability of effective treatments for the condition.

As part of its efforts, AARS has published a social media toolkit for use by its professional members. The kit includes social posts, cards and banners for use on various social media platforms, and inspiration for informative social posts.

"It's very important that patients who have rosacea or think they have rosacea go to board certified dermatologists or licensed healthcare professionals within a dermatology practice, such as physician assistants and nurse practitioners who are educated in dermatology," says AARS President James Q. Del Rosso, DO. "There is no reason patients should not receive treatment, especially as we continue to see effective, tolerable new therapies come to market."

More on Amzeal News

• Sweet Memories Vintage Tees Debuts Historic ORCA™ Beverage Nostalgic Soda Collection
• UK Financial Ltd Celebrates Global Recognition as MayaCat (MCAT) Evolves Into SMCAT — The World's First Meme Coin Under ERC-3643 Compliance
• Ax3.ai Expands Global Leadership to Power the Next Generation of AI Infrastructure with the appointment of Adam Tarnowski as a new CEO and President
• U.S. Military to Benefit from Drone Tech Agreement with NovaSpark Energy, Plus Longer NASA Space Missions via Solar Power Leader: Ascent Solar $ASTI
• CIO Roundtable on Strategic AI Leadership: Redefining Decision-Making in the Age of Agentic Intelligence

Symptoms of rosacea include a generalized red face (called erythema) and flushing (which can occur at any time; often unpredictably), papules and pustules on the face, and thickening of the skin, especially on the nose (called rhinophyma). Some patients have visible blood vessels on the face (telangiectases) and can have eye involvement (ocular rosacea).

Although more than 16 million Americans have rosacea,¹ the condition may be misunderstood and undertreated. In addition to the visible changes and uncomfortable symptoms produced by rosacea, unmanaged rosacea is commonly associated with several untoward effects that impact negatively upon the quality of life of affected individuals.²

The AARS Rosacea Awareness Month toolkit, along with links to all the AARS social platforms, is available to members at https://acneandrosacea.org/RAM2024/.

For more information or to schedule an interview with an AARS expert, please contact: info@aarsmember.org

More on Amzeal News

• $76 Million in Gold & Silver Holdings and Expanding Production — Pioneering the Future of Gold: Asia Broadband Inc. (Stock Symbol: AABB) is Surging
• Wohler announces three SRT monitoring enhancements for its iVAM2-MPEG monitor and the addition of front panel PID selection of A/V/subtitle streams
• Schemawriter.ai launches WordPress plugin as industry leaders confirm - schema markup is critical
• 20 Million Financing to Accelerate Growth and Advance Digital Asset Strategy Secured for Super League (N A S D A Q: SLE)
• uCAR Trading Launches goldsilbermarkt.de, a New Online Shop for Precious Metals

About AARS
The American Acne and Rosacea Society (acneandrosacea.org) is a Section 501(c)(3) non-profit Public Benefit Corporation established in 2005. Our three-part mission is to:
Mission 1: Facilitate the interchange of knowledge and to stimulate education among experts from varied scientific backgrounds in the areas of acne, rosacea and hidradenitis suppurativa.
Mission 2: Improve the care of patients who suffer from acne, rosacea and hidradenitis suppurativa.
Mission 3: Promote and fund acne, rosacea and hidradenitis suppurativa clinical research and mentorship opportunities for dermatology healthcare professionals.

1.  https://www.aad.org/public/diseases/rosacea/wha....
2.  Yang F, et al. Clin Cosmet Investig Dermatol. 2022;15:2807-2816.